Cost and availability of drugs and treatment regimens and availability of drug resistance testing for tuberculosis in Europe

G Günther, L Guglielmetti, C Leu, C Lange, F van Leth… - medRxiv, 2022 - medrxiv.org
Background Access to comprehensive diagnostics and novel anti-tuberculosis medicines is
crucial to improve tuberculosis control at times of emerging Mycobacterium tuberculosis …
被引用次数：1 相关文章
[PDF] archive.org

[PDF][PDF] Cost and availability of drugs and treatment regimens and availability of drug resistance testing for tuberculosis in Europe 2

G Günther, L Guglielmetti, C Leu, C Lange - scholar.archive.org
Background: Access to comprehensive diagnostics and novel anti-tuberculosis medicines is
79 crucial to improve tuberculosis control at times of emerging Mycobacterium tuberculosis …
[HTML] europepmc.org

[HTML][HTML] Cost and availability of drugs and treatment regimens and availability of drug resistance testing for tuberculosis in Europe

G Günther, L Guglielmetti, C Leu, C Lange, F van Leth - 2022 - europepmc.org
Background Access to comprehensive diagnostics and novel anti-tuberculosis medicines is
crucial to improve tuberculosis control at times of emerging Mycobacterium tuberculosis …